Acceleron Reports First Quarter 2019 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Acceleron Pharma (XLRN) Misses Q1 EPS by 15c, Revenues Miss
May 9, 2019 4:42 PM EDTAcceleron Pharma (NASDAQ: XLRN) reported Q1 EPS of ($0.74), $0.15 worse than the analyst estimate of ($0.59). Revenue for the quarter came in at $2.78 million versus the consensus estimate of $7.32 million.
With the submission of marketing applications for luspatercept in the U.S. and... More
